Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients

Pediatric Nephrology

Volumn 10, Issue 5, 1996, Pages 625-630

  Wallot, Michael ^a   Bonzel, Klaus Eugen ^a   Winter, Andreas ^a   Geörger, Birgit ^a   Lettgen, Bernhard ^a   Bald, Martin ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Calcium acetate; Calcium carbonate pediatric; Hemodialysis; Hypercalcemia; Hyperparathyroidism; Parathyroid hormone; Phosphate binder

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CALCIUM; CALCIUM ACETATE; CALCIUM CARBONATE; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; PHOSPHORUS;

ADOLESCENT; ADULT; ARTICLE; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; MALE; ORAL DRUG ADMINISTRATION; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SCHOOL CHILD; VITAMIN BLOOD LEVEL;

EID: 0029742776     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050175     Document Type: Article

References (33)

1. Lopez-Hilker S, Galceran T, Chan YL, Rapp RN, Martin KJ, Slatopolsky E (1986) Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure. J Clin Invest 78:1079-1102
2. Holick MF (1987) Vitamin D and the kidney. Kidney Int 32:912-929
3. Bricker NS, Slatopolsky E, Reiss E, Avioli LV (1969) Calcium, phosphorus, and bone in renal disease and transplantation. Arch Intern Med 123:543-553
4. Bricker NS (1972) On the pathogenesis of the uremic state: an exposition of the "trade- off-hypothesis". N Engl J Med 286:1093-1099
5. Chesney RW, Avioli LV (1992) Childhood renal osteodystrophy. In: Edelmann CM Jr (ed) Pediatric kidney disease, 2nd edn. Little Brown, Boston, pp 647-684
6. Schärer K, Gilli G (1992) Growth retardation in kidney disease. In: Edelmann CM Jr (ed) Pediatric kidney disease, 2nd edn. Little Brown, Boston, pp 593-607
7. Salusky IB, Coburn JW, Foley J, Nelson P, Fine AR (1985) Calcium carbonate as a phosphate binder in children on dialysis (abstract). Kidney Int 27:185
8. Alon U, Davidai G, Bentur L, Berant M, Better OS (1986) Oral calcium carbonate as phosphate-binder in infants and children with chronic renal failure. Miner Electrolyte Metab 12:320-325
9. Andreoli SP, Dunson JW, Bergstein JM (1987) Calcium carbonate is an effective phosphorus binder in children with chronic renal failure. Am J Kidney Dis 9:206-210
10. Clark AG, Oner A, Ward G, Turner C, Rigden SP, Haycock GB, Chantier C (1989) Safety and efficacy of calcium carbonate in children with chronic renal failure. Nephrol Dial Transplant 4:539-544
11. Meric F, Yap P, Bia MJ (1990) Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy. Am J Kidney Dis 16:459-464
12. Mai ML, Emmett MS, Sheikh MS, Santa Ana CA, Schiller L, Fordtran JS (1989) Calcium acetate, an effective phosphorus binder in patients with renal failure. Kidney Int 36:690-695
13. Sheikh MS, Maguire JA, Emmett M, Santa Ana CA, Nicar MJ, Schiller LR, Fordtran JS (1989) Reduction of dietary phosphorus absorption by phosphorus binders: a theoretical, in vitro, and in vivo study. J Clin Invest 83:66-73
14. Slatopolsky E, Weerts C, Lopez-Hilker S, Norwood K, Zink M, Windus D, Delmez J (1986) Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. N Engl J Med 315:157-161
15. Ginsburg D, Kaplan E, Katz A (1973) Hypercalcemia after oral calcium-carbonate therapy in dialysis patients on chronic hemodialysis. Lancet 1:1271-1275
16. 3 supplements on serum calcium and phosphorus in patients on regular hemodialysis treatment. Clin Nephrol 24:147-150
17. Querfeld U, Salusky IB, Fine RN (1988) Treatment of severe hypercalcemia with peritoneal dialysis in an infant with end-stage renal disease. Pediatr Nephrol 2:323-325
18. Schiller LR, Santa Ana CA, Sheikh MS, Emmett M, Fordtran JS (1989) Effect of the time of administration of calcium acetate on phosphorus binding. N Engl J Med 320:1110-1113
19. Morinière P, Djerad M, Boudailliez B, El Esper N, Boitte F, Westeel PF, Compagnon M, Brazier M, Achard JM, Fournier A (1992) Control of predialytic hyperphosphatemia by oral calcium acetate and calcium carbonate. Nephron 60:6-11
20. Schaefer K, Scheer J, Asmus G, Umlauf E, Hagemann J, Von Herrath D (1991) The treatment of uraemic hyperphosphataemia with calcium acetate and calcium carbonate: a comparative study. Nephrol Dial Transplant 6:170-175
21. Caravaca F, Santos I, Cubero JJ, Esparrago JF, Arrobas M, Pizarro JL, Robles R, Sanchez-Casado E (1992) Calcium acetate versus calcium carbonate as phosphate binders in hemodialysis patients. Nephron 60:423-427
22. Hess B, Binswanger U (1990) Long-term administration of calcium acetate efficiently controls severe hyperphosphataemia in haemodialysis patients. Nephrol Dial Transplant 5:630-632
23. Schaefer K, Liebke C, Von Herrath D (1990) Calcium acetate: new hope in the treatment of hyperphosphatemia? Semin Dial 3:65-66
24. Ben Hamida F, El Esper I, Compagnon M, Morinière P, Fournier A (1993) Long-term (6 months) cross-over comparision of calcium acetate with calcium carbonate as phosphate binder. Nephron 63:258-262
25. Coburn JW, Salusky IB (1989) Control of serum phosphorus in uremia. N Engl J Med 320:1140-1142
26. Delmez JA, Slatopolsky E (1992) Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis 19:303-317
27. Pflanz S, Henderson IS, McElduff N, Jones MC (1994) Calcium acetate versus calcium carbonate as phosphate-binding agents in chronic haemodialysis. Nephrol Dial Transplant 9:1121-1124
28. Ring T, Nielsen C, Paulin Andersen S, Behrens JK, Sodemann B, Kornerup HJ (1993) Calcium acetate versus calcium carbonate as phosphorus binders in patients on chronic haemodialysis: a controlled study. Nephrol Dial Transplant 8:341-346
29. Almirall J, Veciana L, Llibre J (1994) Calcium acetate versus calcium carbonate for the control of serum phosphorus in hemodialysis patients. Am J Nephrol 14:192-196
30. Tanner JM (1962) Growth at adolescence, 2nd edn. Blackwell, Oxford
31. Bothe V, Schmidt-Gayk H (1990) Competitive protein-binding assay for the diagnosis of hyper- and hypovitaminosis D. In: Schmidt-Gayk H, Armbruster FP, Bouillon R (eds) Calcium regulating hormones, vitamin D metabolites, and cyclic AMP. Springer, Berlin Heidelberg New York, pp 258-279
32. Hruska KA, Teitelbaum SL (1995) Renal osteodystrophy. N Engl J Med 333:166-174
33. Delmez JA, Tindira C, Grooms P, Dusso A, Windus DW, Slatopolsky E (1989) Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. J Clin Invest 83:1349-1355